These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17447137)

  • 41. Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure.
    Yancy CW
    Drug Saf; 2007; 30(9):765-81. PubMed ID: 17722969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nesiritide: a novel approach for acute heart failure.
    Vichiendilokkul A; Tran A; Racine E
    Ann Pharmacother; 2003 Feb; 37(2):247-58. PubMed ID: 12549957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Diagnostic possibilities and therapy in the acute phase of myocardial infarct].
    Pachinger O
    Wien Med Wochenschr; 1984 Dec; 134(23-24):545-9. PubMed ID: 6442063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of intravenous nitroglycerin in the management of acute decompensated heart failure.
    den Uil CA; Brugts JJ
    Curr Heart Fail Rep; 2015 Feb; 12(1):87-93. PubMed ID: 25301529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography.
    Elkayam U; Akhter MW; Liu M; Hatamizadeh P; Barakat MN
    JACC Cardiovasc Imaging; 2008 Nov; 1(6):765-71. PubMed ID: 19356514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Agents with vasodilator properties in acute heart failure.
    Singh A; Laribi S; Teerlink JR; Mebazaa A
    Eur Heart J; 2017 Feb; 38(5):317-325. PubMed ID: 28201723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemodynamics, diuretics, and nesiritide: a retrospective VMAC analysis.
    Young JB; Cheng M; Mills RM
    Clin Cardiol; 2009 Sep; 32(9):530-6. PubMed ID: 19743494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medical treatment of end-stage heart failure.
    Binetti G; Senni M; Colombo F; Tasca G; Mamprin F; Caporale R; Ferrazzi P; Gamba A; Glauber M; Troise G; Fiocchi R
    Cardiovasc Drugs Ther; 1996 Nov; 10 Suppl 2():617-22. PubMed ID: 9115955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurohormonal activation, the renal dopaminergic system and sodium handling in patients with severe heart failure under vasodilator therapy.
    Ferreira A; Bettencourt P; Dias P; Pestana M; Serrão P; Soares-da-Silva P; Cerqueira-Gomes M
    Clin Sci (Lond); 2001 May; 100(5):557-66. PubMed ID: 11294697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Present and future pharmacotherapy for heart failure.
    Doggrell SA; Brown L
    Expert Opin Pharmacother; 2002 Jul; 3(7):915-30. PubMed ID: 12083991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.
    Costanzo MR; Stevenson LW; Adamson PB; Desai AS; Heywood JT; Bourge RC; Bauman J; Abraham WT
    JACC Heart Fail; 2016 May; 4(5):333-44. PubMed ID: 26874388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of vasodilators in managing congestive heart failure.
    Franciosa JA
    Postgrad Med; 1980 Jan; 67(1):87-91, 94-8. PubMed ID: 6765989
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nesiritide in congestive heart failure associated with acute coronary syndromes: a pilot study of safety and efficacy.
    Peacock WF; Emerman CL; Young J
    J Card Fail; 2004 Apr; 10(2):120-5. PubMed ID: 15101023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review of vasodilators in acute decompensated heart failure: the old and the new.
    Carlson MD; Eckman PM
    J Card Fail; 2013 Jul; 19(7):478-93. PubMed ID: 23834924
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The treatment targets in acute decompensated heart failure.
    Fonarow GC
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S7-S12. PubMed ID: 12439356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of B-type natriuretic peptide in heart failure.
    Nappi JM
    Crit Care Nurs Clin North Am; 2003 Dec; 15(4):461-5. PubMed ID: 14717391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.